Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025GlobeNewsWire • 07/22/25
SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGEBusiness Wire • 07/14/25
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.PRNewsWire • 06/16/25
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product PortfolioGlobeNewsWire • 06/16/25
Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus PharmaceuticalsGlobeNewsWire • 05/29/25
Is the Options Market Predicting a Spike in Supernus Pharmaceuticals (SUPN) Stock?Zacks Investment Research • 05/14/25
Lost Money on Supernus Pharmaceuticals, Inc. (SUPN)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 05/09/25
Levi & Korsinsky Reminds Supernus Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - SUPNAccesswire • 05/08/25
SUPN STOCK ALERT: Levi & Korsinsky Notifies Supernus Pharmaceuticals, Inc. Investors of an Ongoing InvestigationAccesswire • 05/07/25
Supernus (SUPN) Reports Q1 Earnings: What Key Metrics Have to SayZacks Investment Research • 05/07/25
Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 05/06/25
Investors who Lost Money on Supernus Pharmaceuticals, Inc. Should Contact Levi & Korsinsky About an Ongoing Investigation - SUPNAccesswire • 05/06/25
Supernus Pharmaceuticals, Inc. (SUPN) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their RightsAccesswire • 05/05/25
Supernus Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - SUPNAccesswire • 05/02/25
Supernus Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - SUPNAccesswire • 05/01/25
Supernus Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - SUPNAccesswire • 04/30/25
SUPN ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Supernus Pharmaceuticals, Inc. Shareholders Who Lost MoneyAccesswire • 04/29/25
SUPN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Supernus Pharmaceuticals, Inc. investmentAccesswire • 04/28/25
Shareholder Rights Advocates at Levi & Korsinsky Investigate Supernus Pharmaceuticals, Inc. (SUPN) Regarding Possible Securities Fraud ViolationsAccesswire • 04/25/25